Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$499.74 -9.01 (-1.77%)
At close: Oct 16, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Profit After Tax (2009 - 2026)

Updated

Vertex Pharmaceuticals' Profit After Tax came in at $1.1 billion for Q2 2026, up 6.5% from $1.03 billion a year earlier and up 6.6% from the prior quarter.

Analysis

Vertex Pharmaceuticals (VRTX) Profit After Tax (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Vertex Pharmaceuticals reported Profit After Tax of $4.41 billion, up 21.1% year-over-year; for FY2025, it was $3.95 billion.

  • Profit After Tax carries a five-year compound annual growth rate of 7.8% (FY2020 to FY2025).
  • Going back by year, Profit After Tax was -$535.6 million in FY2024, $3.62 billion in FY2023 (+9.0%), $3.32 billion in FY2022 (+41.8%) and $2.34 billion in FY2021 (-13.6%).
  • The five-year range for quarterly Profit After Tax is -$3.59 billion (Q2 2024) to $1.19 billion (Q4 2025).
  • Year-over-year, Profit After Tax has increased for four consecutive quarters, with growth averaging 7.7% over the last seven quarters.
  • The fastest year-over-year change in Profit After Tax over five years came in Q1 2026 (growth of 59.6%), and the weakest in Q1 2025 (a decline of 41.2%).
  • Business Quant data shows VRTX's Profit After Tax at $1.03 billion (Q1 2026), $1.19 billion (Q4 2025) and $1.08 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 5.53 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 3.62 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 2.51 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -10.50 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -246.00 Mn
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn 1.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.10 Bn
Mar 31, 2026 1.03 Bn
Dec 31, 2025 1.19 Bn
Sep 30, 2025 1.08 Bn
Jun 30, 2025 1.03 Bn
Mar 31, 2025 646.30 Mn
Dec 31, 2024 913.00 Mn
Sep 30, 2024 1.05 Bn
Jun 30, 2024 -3.59 Bn
Mar 31, 2024 1.10 Bn
Dec 31, 2023 968.80 Mn
Sep 30, 2023 1.04 Bn
Jun 30, 2023 915.70 Mn
Mar 31, 2023 699.80 Mn
Dec 31, 2022 818.90 Mn
Sep 30, 2022 930.50 Mn
Jun 30, 2022 810.50 Mn
Mar 31, 2022 762.10 Mn
Dec 31, 2021 770.10 Mn
Sep 30, 2021 851.90 Mn
API Access

Vertex Pharmaceuticals Profit After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=VRTX&period=max&api_key=YOUR_API_KEY